Sant Joan Despi, Spain

Joan Huguet Clotet


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Sant Joan Despi, ES (1997 - 2011)
  • Barcelona, ES (2010 - 2018)

Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Joan Huguet Clotet: Innovator in Pharmaceutical Processes

Introduction

Joan Huguet Clotet is a notable inventor based in Sant Joan Despi, Spain. She has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. Her work focuses on improving processes for the preparation of various chemical compounds, which are essential in the development of medications.

Latest Patents

One of her latest patents is titled "Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate." This invention relates to an improved method for producing tafamidis meglumine, which is particularly suitable for industrial-scale manufacture, ensuring excellent purity and high yields. Another significant patent is "Process for preparing (3RS)-3-[(2SR)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide." This invention presents an efficient and environmentally friendly process for preparing the compound with high yield and purity, making it suitable for industrial applications.

Career Highlights

Throughout her career, Joan has worked with various companies, including Inke, S.A. and Vita-Invest, S.A. Her experience in these organizations has contributed to her expertise in pharmaceutical processes and innovation.

Collaborations

Joan has collaborated with notable individuals in her field, including Pere Dalmases Barjoan and Juan Carlos Del Castillo Nieto. These collaborations have further enhanced her work and contributions to the industry.

Conclusion

Joan Huguet Clotet is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in the field. Her patents reflect her commitment to innovation and excellence in the development of essential medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…